$BOLD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Audentes Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Audentes Therapeutics, Inc.. Get notifications about new insider transactions in Audentes Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 27 2019 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | M | 0.78 | 17,000 | 13,260 | 64,751 | |
Feb 27 2019 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Sell | S | 30.00 | 4,000 | 120,000 | 118,700 | 122.7 K to 118.7 K (-3.26 %) |
Feb 27 2019 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 2.19 | 4,000 | 8,760 | 122,700 | 118.7 K to 122.7 K (+3.37 %) |
Feb 27 2019 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Sell | S | 30.00 | 17,000 | 510,000 | 118,700 | 135.7 K to 118.7 K (-12.53 %) |
Feb 27 2019 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 0.78 | 17,000 | 13,260 | 135,700 | 118.7 K to 135.7 K (+14.32 %) |
Feb 08 2019 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | A | 24.74 | 177,450 | 4,390,113 | 177,450 | |
Feb 08 2019 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Grant | A | 0.00 | 63,700 | 0 | 118,700 | 55 K to 118.7 K (+115.82 %) |
Feb 08 2019 | BOLD | Audentes Therapeut ... | Soloway Thomas P | Executive Vice Pres ... | Option Exercise | A | 24.74 | 65,000 | 1,608,100 | 65,000 | |
Feb 08 2019 | BOLD | Audentes Therapeut ... | Soloway Thomas P | Executive Vice Pres ... | Grant | A | 0.00 | 23,333 | 0 | 23,333 | 0 to 23.3 K |
Feb 08 2019 | BOLD | Audentes Therapeut ... | Smith Julie | Director | Option Exercise | A | 24.74 | 16,200 | 400,788 | 16,200 | |
Feb 08 2019 | BOLD | Audentes Therapeut ... | Schuetz Thomas J. | Director | Option Exercise | A | 24.74 | 16,200 | 400,788 | 16,200 | |
Feb 08 2019 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Option Exercise | A | 24.74 | 48,750 | 1,206,075 | 48,750 | |
Feb 08 2019 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Grant | A | 0.00 | 17,500 | 0 | 18,236 | 736 to 18.2 K (+2,377.72 %) |
Feb 08 2019 | BOLD | Audentes Therapeut ... | Morrison Scott W | Director | Option Exercise | A | 24.74 | 16,200 | 400,788 | 16,200 | |
Feb 08 2019 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Option Exercise | A | 24.74 | 16,200 | 400,788 | 16,200 | |
Feb 08 2019 | BOLD | Audentes Therapeut ... | Jarrett Jennifer | Director | Option Exercise | A | 24.74 | 16,200 | 400,788 | 16,200 | |
Feb 08 2019 | BOLD | Audentes Therapeut ... | Holles Natalie C. | President and COO | Option Exercise | A | 24.74 | 65,000 | 1,608,100 | 65,000 | |
Feb 08 2019 | BOLD | Audentes Therapeut ... | Holles Natalie C. | President and COO | Grant | A | 0.00 | 23,333 | 0 | 56,723 | 33.4 K to 56.7 K (+69.88 %) |
Feb 08 2019 | BOLD | Audentes Therapeut ... | Goldberg Mark Alan | Director | Option Exercise | A | 24.74 | 16,200 | 400,788 | 16,200 | |
Jan 25 2019 | BOLD | Audentes Therapeut ... | Holles Natalie C. | President and COO | Option Exercise | M | 2.76 | 8,300 | 22,949 | 156,429 | |
Jan 25 2019 | BOLD | Audentes Therapeut ... | Holles Natalie C. | President and COO | Buy | M | 2.76 | 8,300 | 22,949 | 33,390 | 25.1 K to 33.4 K (+33.08 %) |
Jan 04 2019 | BOLD | Audentes Therapeut ... | Mosbrooker Eric | SVP, Chief Commerci ... | Option Exercise | A | 22.01 | 87,750 | 1,931,378 | 87,750 | |
Jan 04 2019 | BOLD | Audentes Therapeut ... | Mosbrooker Eric | SVP, Chief Commerci ... | Grant | A | 0.00 | 31,500 | 0 | 31,800 | 300 to 31.8 K (+10,500.00 %) |
Dec 27 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 18.50 | 10,000 | 184,951 | 32,343 | 42.3 K to 32.3 K (-23.62 %) |
Dec 27 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 18.71 | 1,000 | 18,713 | 558 | 1.6 K to 558 (-64.18 %) |
Dec 27 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 18.70 | 1,000 | 18,701 | 17,678 | 18.7 K to 17.7 K (-5.35 %) |
Dec 27 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 18.67 | 20,000 | 373,434 | 325,799 | 345.8 K to 325.8 K (-5.78 %) |
Dec 10 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | M | 0.78 | 40,000 | 31,200 | 31,702 | |
Dec 10 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 0.78 | 40,000 | 31,200 | 55,000 | 15 K to 55 K (+266.67 %) |
Nov 16 2018 | BOLD | Audentes Therapeut ... | NEWMAN MARY | SVP, Regulatory Aff ... | Grant | A | 19.64 | 660 | 12,959 | 660 | 0 to 660 |
Nov 16 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Grant | A | 19.64 | 736 | 14,451 | 736 | 0 to 736 |
Nov 16 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 22.49 | 4,000 | 89,960 | 3,555 | 7.6 K to 3.6 K (-52.95 %) |
Nov 16 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 22.49 | 20,000 | 449,800 | 345,799 | 365.8 K to 345.8 K (-5.47 %) |
Oct 02 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Option Exercise | M | 0.79 | 10,000 | 7,900 | 50,870 | |
Oct 02 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Sell | S | 35.60 | 4,699 | 167,283 | 0 | 4.7 K to 0 (-100.00 %) |
Oct 02 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Buy | M | 0.79 | 4,699 | 3,712 | 4,699 | 0 to 4.7 K |
Oct 02 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Sell | S | 36.32 | 200 | 7,263 | 0 | 200 to 0 (-100.00 %) |
Oct 02 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Buy | M | 0.79 | 200 | 158 | 200 | 0 to 200 |
Oct 02 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Sell | S | 37.82 | 3,900 | 147,512 | 0 | 3.9 K to 0 (-100.00 %) |
Oct 02 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Buy | M | 0.79 | 3,900 | 3,081 | 3,900 | 0 to 3.9 K |
Oct 02 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Sell | S | 38.85 | 1,101 | 42,777 | 0 | 1.1 K to 0 (-100.00 %) |
Oct 02 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Buy | M | 0.79 | 1,101 | 870 | 1,101 | 0 to 1.1 K |
Oct 02 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Sell | S | 39.52 | 100 | 3,952 | 0 | 100 to 0 (-100.00 %) |
Oct 02 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Buy | M | 0.79 | 100 | 79 | 100 | 0 to 100 |
Oct 02 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | M | 0.78 | 21,000 | 16,380 | 71,702 | |
Oct 02 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Sell | S | 37.70 | 8,078 | 304,573 | 15,000 | 23.1 K to 15 K (-35.00 %) |
Oct 02 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 0.78 | 8,078 | 6,301 | 23,078 | 15 K to 23.1 K (+53.85 %) |
Oct 02 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Sell | S | 38.58 | 5,448 | 210,162 | 15,000 | 20.4 K to 15 K (-26.64 %) |
Oct 02 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 0.78 | 5,448 | 4,249 | 20,448 | 15 K to 20.4 K (+36.32 %) |
Oct 02 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Sell | S | 38.04 | 5,330 | 202,732 | 15,000 | 20.3 K to 15 K (-26.22 %) |
Oct 02 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 0.78 | 5,330 | 4,157 | 20,330 | 15 K to 20.3 K (+35.53 %) |
Oct 02 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Sell | S | 39.14 | 2,144 | 83,905 | 15,000 | 17.1 K to 15 K (-12.51 %) |
Oct 02 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 0.78 | 2,144 | 1,672 | 17,144 | 15 K to 17.1 K (+14.29 %) |
Oct 02 2018 | BOLD | Audentes Therapeut ... | GRAY JOHN T. | SVP, Chief Scientif ... | Option Exercise | M | 1.05 | 87 | 91 | 71,669 | |
Oct 02 2018 | BOLD | Audentes Therapeut ... | GRAY JOHN T. | SVP, Chief Scientif ... | Sell | S | 40.00 | 87 | 3,480 | 0 | 87 to 0 (-100.00 %) |
Oct 02 2018 | BOLD | Audentes Therapeut ... | GRAY JOHN T. | SVP, Chief Scientif ... | Buy | M | 1.05 | 87 | 91 | 87 | 0 to 87 |
Sep 26 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 37.45 | 10,000 | 374,536 | 42,343 | 52.3 K to 42.3 K (-19.10 %) |
Sep 26 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 37.27 | 1,000 | 37,267 | 1,558 | 2.6 K to 1.6 K (-39.09 %) |
Sep 26 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 37.27 | 1,000 | 37,266 | 18,678 | 19.7 K to 18.7 K (-5.08 %) |
Sep 26 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 37.25 | 1,000 | 37,250 | 7,555 | 8.6 K to 7.6 K (-11.69 %) |
Sep 26 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 37.76 | 200 | 7,551 | 365,799 | 366 K to 365.8 K (-0.05 %) |
Sep 26 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 37.35 | 19,800 | 739,510 | 365,999 | 385.8 K to 366 K (-5.13 %) |
Sep 24 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | M | 0.78 | 15,000 | 11,700 | 92,702 | |
Sep 24 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 0.78 | 15,000 | 11,700 | 15,000 | 0 to 15 K |
Sep 20 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | M | 2.19 | 12,952 | 28,365 | 128,345 | |
Sep 20 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Sell | S | 40.00 | 12,952 | 518,080 | 0 | 13 K to 0 (-100.00 %) |
Sep 20 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 2.19 | 12,952 | 28,365 | 12,952 | 0 to 13 K |
Jul 05 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Option Exercise | M | 0.79 | 5,011 | 3,959 | 60,870 | |
Jul 05 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Option Exercise | M | 0.79 | 4,989 | 3,941 | 65,881 | |
Jul 05 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Sell | S | 38.79 | 5,011 | 194,364 | 0 | 5 K to 0 (-100.00 %) |
Jul 05 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Buy | M | 0.79 | 5,011 | 3,959 | 5,011 | 0 to 5 K |
Jul 05 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Sell | S | 38.02 | 4,989 | 189,704 | 0 | 5 K to 0 (-100.00 %) |
Jul 05 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Buy | M | 0.79 | 4,989 | 3,941 | 4,989 | 0 to 5 K |
Jul 05 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | M | 0.78 | 23,147 | 18,055 | 107,702 | |
Jul 05 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | M | 0.78 | 26,901 | 20,983 | 130,849 | |
Jul 05 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | M | 0.78 | 1,401 | 1,093 | 157,750 | |
Jul 05 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Option Exercise | M | 0.78 | 19,599 | 15,287 | 159,151 | |
Jul 05 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Sell | S | 40.04 | 23,147 | 926,852 | 0 | 23.1 K to 0 (-100.00 %) |
Jul 05 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 0.78 | 23,147 | 18,055 | 23,147 | 0 to 23.1 K |
Jul 05 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Sell | S | 40.05 | 26,901 | 1,077,460 | 0 | 26.9 K to 0 (-100.00 %) |
Jul 05 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 0.78 | 26,901 | 20,983 | 26,901 | 0 to 26.9 K |
Jul 05 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Sell | S | 38.78 | 1,401 | 54,330 | 0 | 1.4 K to 0 (-100.00 %) |
Jul 05 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 0.78 | 1,401 | 1,093 | 1,401 | 0 to 1.4 K |
Jul 05 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Sell | S | 38.33 | 19,599 | 751,194 | 0 | 19.6 K to 0 (-100.00 %) |
Jul 05 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | Chief Executive Off ... | Buy | M | 0.78 | 19,599 | 15,287 | 19,599 | 0 to 19.6 K |
Jun 27 2018 | BOLD | Audentes Therapeut ... | NEWMAN MARY | SVP, Regulatory Aff ... | Option Exercise | M | 2.19 | 8,545 | 18,673 | 15,272 | |
Jun 27 2018 | BOLD | Audentes Therapeut ... | NEWMAN MARY | SVP, Regulatory Aff ... | Sell | S | 41.37 | 300 | 12,412 | 0 | 300 to 0 (-100.00 %) |
Jun 27 2018 | BOLD | Audentes Therapeut ... | NEWMAN MARY | SVP, Regulatory Aff ... | Buy | M | 2.19 | 300 | 656 | 300 | 0 to 300 |
Jun 27 2018 | BOLD | Audentes Therapeut ... | NEWMAN MARY | SVP, Regulatory Aff ... | Sell | S | 40.77 | 8,245 | 336,169 | 0 | 8.2 K to 0 (-100.00 %) |
Jun 27 2018 | BOLD | Audentes Therapeut ... | NEWMAN MARY | SVP, Regulatory Aff ... | Buy | M | 2.19 | 8,245 | 18,017 | 8,245 | 0 to 8.2 K |
Jun 27 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 41.27 | 210 | 8,667 | 52,343 | 52.6 K to 52.3 K (-0.40 %) |
Jun 27 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 40.86 | 9,790 | 400,037 | 52,553 | 62.3 K to 52.6 K (-15.70 %) |
Jun 27 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 41.47 | 100 | 4,147 | 2,558 | 2.7 K to 2.6 K (-3.76 %) |
Jun 27 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 40.74 | 900 | 36,662 | 2,658 | 3.6 K to 2.7 K (-25.30 %) |
Jun 27 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 41.46 | 100 | 4,146 | 19,678 | 19.8 K to 19.7 K (-0.51 %) |
Jun 27 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 40.79 | 900 | 36,712 | 19,778 | 20.7 K to 19.8 K (-4.35 %) |
Jun 27 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 40.78 | 1,000 | 40,783 | 8,555 | 9.6 K to 8.6 K (-10.47 %) |
Jun 27 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 41.31 | 1,140 | 47,088 | 385,799 | 386.9 K to 385.8 K (-0.29 %) |
Jun 27 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 40.36 | 18,860 | 761,256 | 386,939 | 405.8 K to 386.9 K (-4.65 %) |
Jun 22 2018 | BOLD | Audentes Therapeut ... | Nagler David | SVP, HR & Corp. Aff ... | Option Exercise | M | 2.19 | 5,000 | 10,926 | 32,347 | |
Jun 22 2018 | BOLD | Audentes Therapeut ... | Nagler David | SVP, HR & Corp. Aff ... | Sell | S | 46.02 | 300 | 13,806 | 0 | 300 to 0 (-100.00 %) |
Jun 22 2018 | BOLD | Audentes Therapeut ... | Nagler David | SVP, HR & Corp. Aff ... | Buy | M | 2.19 | 300 | 656 | 300 | 0 to 300 |
Jun 22 2018 | BOLD | Audentes Therapeut ... | Nagler David | SVP, HR & Corp. Aff ... | Sell | S | 45.25 | 4,700 | 212,655 | 0 | 4.7 K to 0 (-100.00 %) |
Jun 22 2018 | BOLD | Audentes Therapeut ... | Nagler David | SVP, HR & Corp. Aff ... | Buy | M | 2.19 | 4,700 | 10,270 | 4,700 | 0 to 4.7 K |
Jun 08 2018 | BOLD | Audentes Therapeut ... | Smith Julie | Director | Option Exercise | A | 38.65 | 10,000 | 386,500 | 10,000 | |
Jun 08 2018 | BOLD | Audentes Therapeut ... | Schuetz Thomas J. | Director | Option Exercise | A | 38.65 | 10,000 | 386,500 | 10,000 | |
Jun 08 2018 | BOLD | Audentes Therapeut ... | PARMAR KUSH | Director | Option Exercise | A | 38.65 | 10,000 | 386,500 | 10,000 | |
Jun 08 2018 | BOLD | Audentes Therapeut ... | Morrison Scott W | Director | Option Exercise | A | 38.65 | 10,000 | 386,500 | 10,000 | |
Jun 08 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Option Exercise | A | 38.65 | 10,000 | 386,500 | 10,000 | |
Jun 08 2018 | BOLD | Audentes Therapeut ... | Jarrett Jennifer | Director | Option Exercise | A | 38.65 | 10,000 | 386,500 | 10,000 | |
Jun 08 2018 | BOLD | Audentes Therapeut ... | Goldberg Mark Alan | Director | Option Exercise | A | 38.65 | 10,000 | 386,500 | 10,000 | |
Jun 04 2018 | BOLD | Audentes Therapeut ... | Holles Natalie C. | President and COO | Option Exercise | M | 2.76 | 5,090 | 14,073 | 164,729 | |
Jun 04 2018 | BOLD | Audentes Therapeut ... | Holles Natalie C. | President and COO | Buy | M | 2.76 | 5,090 | 14,073 | 25,090 | 20 K to 25.1 K (+25.45 %) |
May 23 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Option Exercise | M | 0.78 | 20,300 | 15,834 | 178,750 | |
May 23 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Sell | S | 38.30 | 6,700 | 256,610 | 0 | 6.7 K to 0 (-100.00 %) |
May 23 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Buy | M | 0.78 | 6,700 | 5,226 | 6,700 | 0 to 6.7 K |
May 23 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Sell | S | 38.08 | 13,600 | 517,888 | 0 | 13.6 K to 0 (-100.00 %) |
May 23 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Buy | M | 0.78 | 13,600 | 10,608 | 13,600 | 0 to 13.6 K |
May 08 2018 | BOLD | Audentes Therapeut ... | Holles Natalie C. | President and COO | Option Exercise | A | 36.39 | 25,000 | 909,750 | 25,000 | |
Apr 04 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Option Exercise | M | 0.78 | 700 | 546 | 199,050 | |
Apr 04 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Sell | S | 30.01 | 700 | 21,009 | 0 | 700 to 0 (-100.00 %) |
Apr 04 2018 | BOLD | Audentes Therapeut ... | Patterson Matthew R | President & CEO | Buy | M | 0.78 | 700 | 546 | 700 | 0 to 700 |
Apr 02 2018 | BOLD | Audentes Therapeut ... | NEWMAN MARY | SVP, Regulatory Aff ... | Option Exercise | M | 2.19 | 10,000 | 21,900 | 23,817 | |
Apr 02 2018 | BOLD | Audentes Therapeut ... | NEWMAN MARY | SVP, Regulatory Aff ... | Sell | S | 31.62 | 400 | 12,647 | 0 | 400 to 0 (-100.00 %) |
Apr 02 2018 | BOLD | Audentes Therapeut ... | NEWMAN MARY | SVP, Regulatory Aff ... | Buy | M | 2.19 | 400 | 876 | 400 | 0 to 400 |
Apr 02 2018 | BOLD | Audentes Therapeut ... | NEWMAN MARY | SVP, Regulatory Aff ... | Sell | S | 30.79 | 5,524 | 170,085 | 0 | 5.5 K to 0 (-100.00 %) |
Apr 02 2018 | BOLD | Audentes Therapeut ... | NEWMAN MARY | SVP, Regulatory Aff ... | Buy | M | 2.19 | 5,524 | 12,098 | 5,524 | 0 to 5.5 K |
Apr 02 2018 | BOLD | Audentes Therapeut ... | NEWMAN MARY | SVP, Regulatory Aff ... | Sell | S | 29.66 | 4,076 | 120,895 | 0 | 4.1 K to 0 (-100.00 %) |
Apr 02 2018 | BOLD | Audentes Therapeut ... | NEWMAN MARY | SVP, Regulatory Aff ... | Buy | M | 2.19 | 4,076 | 8,926 | 4,076 | 0 to 4.1 K |
Mar 29 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Option Exercise | M | 0.79 | 7,800 | 6,162 | 70,870 | |
Mar 29 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Sell | S | 30.03 | 7,800 | 234,195 | 0 | 7.8 K to 0 (-100.00 %) |
Mar 29 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Buy | M | 0.79 | 7,800 | 6,162 | 7,800 | 0 to 7.8 K |
Mar 28 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Option Exercise | M | 0.79 | 300 | 237 | 78,670 | |
Mar 28 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Option Exercise | M | 0.79 | 1,900 | 1,501 | 78,970 | |
Mar 28 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Sell | S | 30.00 | 300 | 9,000 | 0 | 300 to 0 (-100.00 %) |
Mar 28 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Buy | M | 0.79 | 300 | 237 | 300 | 0 to 300 |
Mar 28 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Sell | S | 30.00 | 1,900 | 57,000 | 0 | 1.9 K to 0 (-100.00 %) |
Mar 28 2018 | BOLD | Audentes Therapeut ... | PRASAD SUYASH | Senior VP & Chief M ... | Buy | M | 0.79 | 1,900 | 1,501 | 1,900 | 0 to 1.9 K |
Mar 28 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 29.27 | 6,600 | 193,152 | 62,343 | 68.9 K to 62.3 K (-9.57 %) |
Mar 28 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 28.35 | 18,400 | 521,666 | 68,943 | 87.3 K to 68.9 K (-21.07 %) |
Mar 28 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 29.57 | 483 | 14,282 | 3,558 | 4 K to 3.6 K (-11.95 %) |
Mar 28 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 28.32 | 517 | 14,642 | 4,041 | 4.6 K to 4 K (-11.34 %) |
Mar 28 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 29.57 | 400 | 11,829 | 20,678 | 21.1 K to 20.7 K (-1.90 %) |
Mar 28 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 28.38 | 600 | 17,028 | 21,078 | 21.7 K to 21.1 K (-2.77 %) |
Mar 28 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 29.46 | 500 | 14,732 | 9,555 | 10.1 K to 9.6 K (-4.97 %) |
Mar 28 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 28.28 | 500 | 14,142 | 10,055 | 10.6 K to 10.1 K (-4.74 %) |
Mar 28 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 29.95 | 1,732 | 51,873 | 405,799 | 407.5 K to 405.8 K (-0.42 %) |
Mar 28 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 29.57 | 6,700 | 198,119 | 407,531 | 414.2 K to 407.5 K (-1.62 %) |
Mar 28 2018 | BOLD | Audentes Therapeut ... | LANGE LOUIS G | Director | Sell | S | 29.00 | 11,568 | 335,472 | 414,231 | 425.8 K to 414.2 K (-2.72 %) |
Mar 12 2018 | BOLD | Audentes Therapeut ... | ORBIMED ADVISORS LLC | 10% Owner | Sell | S | 34.92 | 16,937 | 591,440 | 3,539,997 | 3.6 M to 3.5 M (-0.48 %) |